iTBS for Acute Ischemic Stroke After Thrombectomy
RecruitingNCT06941961Phase: NAStarted 2025-04-25
Summary
The goal of this randomized, single-blind, parallel-controlled clinical trial is to evaluate the efficacy and safety of intermittent theta burst stimulation (iTBS) as an adjunctive therapy for acute a
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
85 Years
Locations
The First Hospital of Jilin UniversityChangchun, Jilin, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT06941961